Alivus Life Sciences Q2 Results

  • BSE: 543322
  • NSE: ALIVUS
  • ISIN: INE03Q201024
  • Sector: Biotechnology & Drugs
BSE
875.0013.20 (1.53%)
Volume9.27 K
Updated: Fri 23 Jan, 2026 | 15:29:54
NSE
883.5022.00 (2.55%)
Volume2.09 L
Updated: Fri 23 Jan, 2026 | 15:40:01
Today: 869.50
908.00
52-Wk: 827.10
1,259.75

Technical Trends

Long Term
Considers price movement over the last 6 months

Long Term
Not Available

Short Term
Considers price movement over the last 1-2 weeks

Not Available
  • Bearish
  • Moderately Bearish
  • Neutral
  • Moderately Bullish
  • Bullish

Insight: Trends unavailable at the moment.

Q2 Results Highlights

Quarter ended Sep 25

    Note: Comparison is on QoQ basis

    Quarterly - Alivus Life Sciences Q2 Results

    *All figures in crores except per share values
    Fiscal PeriodSep 25Jun 25QoQ CompSep 24YoY Comp
    Total Operating Expense 427.25446.60-4.33%387.6110.22%
    Depreciation/ Amortization 18.4417.068.03%15.0922.14%
    Operating Income 160.73155.253.54%119.2734.77%
    Net Income 130.03121.546.99%95.3236.42%
    Other Operating Expenses Total 93.4997.57-4.18%84.8910.14%
    Net Income Before Taxes 174.14162.986.84%127.4636.63%
    Total Revenue 587.98601.85-2.30%506.8816.00%
    Selling/ General/ Admin Expenses Total 66.4061.587.83%62.446.34%
    Diluted Normalized EPS 10.589.887.09%7.7536.52%

    EQUITY QUICK LINKS

    FROM MARKETS

    RELATED LINKS

    Recommended For You

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe

        Trending Now In Market

          ✕

          Wait for it…

          Log in to our website to save your bookmarks. It'll just take a moment.

          ✕

          Wait for it…

          Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.